prognostic indicators

News
Deep Learning Model Accurately Predicts Risk of OS in Gastric Cancer
06/22/2020
A novel deep learning model may accurately predict the risk for overall survival (OS) based on computed tomography (CT) images. Improved risk prediction of OS in gastric cancer is needed in order to guide...
A novel deep learning model may accurately predict the risk for overall survival (OS) based on computed tomography (CT) images. Improved risk prediction of OS in gastric cancer is needed in order to guide...
A...
06/22/2020
Journal of Clinical Pathways
News
Predicting Clinical Outcomes of Patients With High-Risk MCL
06/18/2020
Patients with high-risk mantle cell lymphoma (MCL) biology—defined by blastoid variance, Ki-67 greater than 30%, or high p53 immunohistochemistry expression—are more likely to experience shorter failure-free and...
Patients with high-risk mantle cell lymphoma (MCL) biology—defined by blastoid variance, Ki-67 greater than 30%, or high p53 immunohistochemistry expression—are more likely to experience shorter failure-free and...
...
06/18/2020
Journal of Clinical Pathways
News
Hypercalcemia as a Biomarker for Aggressive Disease in Patients With B-Cell Lymphoma
05/13/2020
For patients with diffuse large B-cell lymphoma (DLBCL), presence of hypercalcemia at diagnosis correlates with negative prognostic factors and a short diagnosis-to-treatment interval, according to a retrospective...
For patients with diffuse large B-cell lymphoma (DLBCL), presence of hypercalcemia at diagnosis correlates with negative prognostic factors and a short diagnosis-to-treatment interval, according to a retrospective...
For...
05/13/2020
Journal of Clinical Pathways
Research in Review
Patients With MCL and a Specific Mutation in Need of Alternative Frontline Therapies
08/21/2017
JCP Editors
Patients with mantle cell lymphoma (MCL) should be stratified based on the status of a specific mutation and considered for alternative first-line therapy, according to a new study published in Blood (online August...
Patients with mantle cell lymphoma (MCL) should be stratified based on the status of a specific mutation and considered for alternative first-line therapy, according to a new study published in Blood (online August...
...
08/21/2017
Journal of Clinical Pathways
Research in Review
Pancreatic Cancer Guidelines Do Not Cover Some Targetable Mutations
08/11/2017
JCP Editors
Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...
Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...
...
08/11/2017
Journal of Clinical Pathways
Research in Review
End-of-Life Care Underutilized Among Older Patients With AML
08/10/2017
JCP Editors
Use of end-of-life care and hospice services is suboptimal among older patients with acute myeloid leukemia (AML), according to a recent study published in the Journal of Clinical Oncology (online August 7, 2017;...
Use of end-of-life care and hospice services is suboptimal among older patients with acute myeloid leukemia (AML), according to a recent study published in the Journal of Clinical Oncology (online August 7, 2017;...
Use of...
08/10/2017
Journal of Clinical Pathways
Research in Review
Impact of Vitamin D Deficiency on Relapse in Patients With Myeloid Malignancies
08/10/2017
JCP Editors
Patients with myeloid malignancies who have vitamin D deficiency before undergoing allogeneic stem cell transplantation (alloSCT) are at a higher risk of relapse, according to recent research published in the Journal...
Patients with myeloid malignancies who have vitamin D deficiency before undergoing allogeneic stem cell transplantation (alloSCT) are at a higher risk of relapse, according to recent research published in the Journal...
...
08/10/2017
Journal of Clinical Pathways
Research in Review
Novel Ovarian Cancer Subtypes Associated With Survival Outcomes Following Surgery
08/02/2017
JCP Editors
High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...
High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...
...
08/02/2017
Journal of Clinical Pathways
Research in Review
Prognostic Awareness Affects EOL Decisions, QOL for Cancer Patients
07/21/2017
JCP Editors
Terminally ill patients’ understanding of their prognosis within the last six months of their life often times remain unchanged, according to a recent study. ----- Related Content Oncology care models improve...
Terminally ill patients’ understanding of their prognosis within the last six months of their life often times remain unchanged, according to a recent study. ----- Related Content Oncology care models improve...
...
07/21/2017
Journal of Clinical Pathways
Research in Review
Altered B-Cell Composition May Impact Immunotherapy Effectiveness in AML
07/13/2017
JCP Editors
Initial chemotherapy often alters B-cell composition and immunity in patients with acute myeloid leukemia (AML), which may have implications for the success of further immunotherapy, according to research published...
Initial chemotherapy often alters B-cell composition and immunity in patients with acute myeloid leukemia (AML), which may have implications for the success of further immunotherapy, according to research published...
...
07/13/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use